Small copper complexes for treatment of acquired and inherited copper deficiency syndromes

Small Molecule Therapy for Genetic Disease

Volumn , Issue , 2010, Pages 202-212

  Kaler, Stephen G ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876875943     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511777905.015     Document Type: Chapter

References (33)

1. Kaler SG. Menkes disease, L.A. Barness, A. Advances in Pediatrics, Volume 41, C.V. Mosby, 263-304, 1994
2. Desai V, Kaler SG. The role of copper in human neurological disorders Am J Clin Nutr. 2008;88:855-858
3. Goodman BP, Bosch EP, Ross MA, Hoffman-Snyder C, Dodick DD, Smith BE. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J Neurol NeurosurgPsychiatry 2009;80:524-527.
4. Kumar N, Ahlskog JE, Klein CJ, Port JD. Imaging features of copper deficiency myelopathy: A study of 25 cases. Neuroradiology. 2006;48(2):78-83
5. Kelkar P, Chang S, Muley SA. Response to oral supplementation in copper deficiency myeloneuropathy. J Clin Neuromuscul Dis. 2008;10(1):1-3
6. Spain RI, Leist TP, De Sousa EA. When metals compete: A case of copper-deficiency myeloneuropathy and anemia. Nat Clin Pract Neurol. 2009;5(2):106-111
7. Zara G, Grassivaro F, Brocadello F, Manara R, Pesenti FF. Case of sensory ataxic ganglionopathy-myelopathy in copper deficiency. J Neurol Sci. 2009;277(1-2):184-186
8. Weihl CC, Lopate G. Motor neuron disease associated with copper deficiency. Muscle Nerve. 2006;34(6):789-793
9. Kaler SG, Holmes CS, Goldstein DS, Tang JR, Godwin SC, Donsante A, Liew CJ, Sato S, Patronas N. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008;358:605-614
10. Kaler SG, Tang JR, Donsante A, Kaneski C. Translational read-through of a nonsense mutation in ATP7A. Ann Neurol. 2009;65:108-113
11. Baerlocher K, Nadal D. Das Menkes-syndrom. Ergeb Inn Med Kinderheilkd. 1988;57:77-144
12. Goldstein DS, Holmes CS, Kaler SG. Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of Menkes disease. Neurochem Res. 2009;34:1464-1468
13. Kaler SG, Goldstein DS, Holmes C, Salerno JA, Gahl WA. Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease. Ann Neurol. 1993;33:171-175
14. Eipper BA, Mains RE, Glembotski CC. Identification in pituitary tissue of a peptide a-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. ProcNatl Acad Sci USA. 1983;80:5144-5148
15. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62
16. Gunn TR, McFarlane S, Phillips LI. Difficulties in the neonatal diagnosis of Menkes' kinky hair syndrome-trichopoliodystrophy. Clin Pediatr. 1984;23:514-516
17. Sartoris DJ, Luzzatti L, Weaver DD, Macfarlane JD, Hollister DW, Parker BR. Type IX Ehlers-Danlos syndrome. A new variant with pathognomonic radiographic features. Radiology. 1984;152:665-670
18. Kaler SG, Gallo LK, Proud VK, Percy AK, Mark Y, Segal NA, Goldstein DS, Holmes CS, Gahl WA. Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet. 1994;8:195-202
19. Tang J, Robertson SP, Lem KE, Godwin SC, Kaler SG. Functional copper transport explains neurologic sparing in occipital horn syndrome. Genet Med. 2006;8(11):711-718
20. Kennerson ML, Nicholson GA, Kaler SG, Kowalski B, Mercer JF, Tang J, Llanos RM, Chu S, Takata RI, Speck-Martins CE, Baets J, Almeida-Souza L, Fischer D, Timmerman V, Taylor PE, Scherer SS, Ferguson TA, Bird TD, De Jonghe P, Feely SM, Shy ME, Garbern JY: Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet. 2010;86:343-352
21. Fraser AS, Sobey S, Spicer CC. Mottled, a sex-modified lethal in the house mouse. J Genet. 1953;51:217-221
22. Hunt DM. Primary defect in copper transport underlies mottled mutants in the mouse. Nature. 1974;249:852-854
23. Hunt DM. A study of copper treatment and tissue copper levels in the murine congenital copper deficiency, mottled. Life Sci. 1976;19(12):1913-1919
24. Linder CC. Genetic variables that influence phenotype. ILAR J. 2006;47:132-140
25. Kaler SG, Donsante A, Tang J, Goldstein D, Holmes C, Sullivan P, Centeno J. Brain-directed AAV5 gene therapy, in combination with copper, rescues a murine model of severe Menkes disease. Session 42/Abstract 143, Annual Meeting of the American Society of Human Genetics. Available at: http://www.ashg.org/2009meeting/
26. Baute D, Arieli D, Neese F, Zimmermann H, Weckhuysen BM, Goldfarb D. Carboxylate binding in copper histidine complexes in solution and in zeolite. Y: X- and W-band pulsed EPR/ENDOR combined with DFT calculations. J Am Chem Soc. 2004;126:11733-11745.
27. Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol. 2008;4:176-185
28. McArdle HJ, Gross SM, Danks DM, Wedd AG. Role of albumin's copper binding site in copper uptake by mouse hepatocytes. Am J Physiol. 1990;258(6 Pt 1):G988-G991
29. Greenough M, Pase L, Voskoboinik I, Petris MJ, O'Brien AW, Camakaris J. Signals regulating trafficking of Menkes (MNK;ATP7A) copper-translocating P-type ATPase in polarized MDCK cells. Am J Physiol Cell Physiol. 2004;287:C1463-C1471
30. Aoki I, Wu YJ, Silva AC, Lynch RM, Koretsky AP. In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage. 2004;22:1046-1059
31. Choi BS, Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14-21
32. Quinton PM, Wright EM, Tormey JM. Localization of sodium pumps in the choroid plexus epithelium. J Cell Biol. 1973;58:724-730
33. Alper SL, Stuart-Tilley A, Simmons CF, Brown D, Drenckhahn D. The fodrin-ankyrin cytoskeleton of choroid plexus preferentially colocalizes with apical Na+K+-ATPase rather than with basolateral anion exchanger AE2. J Clin Invest. 1994;93:1430-1438